Lactobacillus salivarius
Lactobacillus salivarius LS01
DSM 22775 (LS01)
Easing eczema symptoms and supporting skin barrier repair.
Quick Overview
At a Glance
Researched Benefits
- Clinically shown to reduce eczema severity scores in both adults and children — including itch, redness, and skin inflammation.
- Works from the inside out via the gut-skin axis, addressing the immune root cause of flare-ups rather than just masking surface symptoms.
- Demonstrated benefits that can persist even after finishing the supplement course, suggesting lasting immune rebalancing.
- Excellent safety record across multiple randomized, placebo-controlled trials — well tolerated from infants to adults.
Usage & Application
Clinically Studied Dosage
1–2 Billion CFU/day (up to 10 Billion CFU/day in some formulations)
Available Forms
Clinical Evidence
Eczema Relief and Skin Barrier Repair from a Clinically Studied Probiotic: Lactobacillus salivarius LS01
Lactobacillus salivarius LS01 (lab code DSM 22775) is a naturally occurring lactic acid bacterium that was originally identified and selected specifically for its exceptional ability to calm an overactive immune system — making it one of the most intensively studied probiotic strains for skin and allergy conditions. Unlike many generic 'gut health' probiotics, LS01 earned its clinical reputation through a focused body of research targeting the gut-skin axis: the invisible superhighway linking what's happening in your digestive tract to what shows up on your face, arms, and body. Think of LS01 as a skilled peacekeeper stationed inside your gut. When your immune system is firing too many alarm signals — the kind that make skin angry, red, and itchy — this strain steps in, helps dial down the noise, and nudges your body's defenses back toward a calmer, more balanced state.
The most compelling evidence for LS01 centers on atopic dermatitis, the medical name for the chronic, relapsing form of eczema that affects millions of people worldwide. In clinical studies involving both adults and children, those who took LS01 daily experienced noticeable reductions in two key measures: the objective severity of their skin inflammation (how bad the eczema actually looked) and the impact it had on their everyday life — things like sleep quality, confidence, and the urge to scratch constantly. Children as young as infants and adults up to their mid-forties have participated in these trials, and importantly, the benefits didn't stop the moment supplementation ended — improvements in skin scores and itch levels persisted even weeks after the probiotic course was finished. Beyond eczema, LS01 has shown promise in other immune-driven skin and allergy conditions. Research into chronic spontaneous urticaria (stubborn hives that won't go away with standard antihistamines) found that some patients experienced meaningful symptom relief when LS01 was added to their routine. Its immune-balancing action has also attracted attention from researchers studying allergic asthma in children, where a large trial found that a probiotic blend featuring LS01 significantly cut the number of asthma flare-ups. What ties all of this together is one core mechanism: LS01 consistently helps shift the immune system away from an inflammatory, allergy-prone state and toward a healthier, more regulated one — all by working through the gut.
One of the most reassuring things about LS01 is its safety profile. Across all published clinical trials — involving infants, children, and adults — no serious adverse events were recorded. It is generally very well tolerated, even at higher doses. As with any supplement, people who are immunocompromised, pregnant, or managing a serious medical condition should consult their doctor before starting a new probiotic regimen. For most healthy individuals, LS01 is typically taken once or twice daily, often in powdered sachet form that can be mixed into water or a cool drink (heat can reduce live bacteria counts, so avoid mixing with hot beverages). While results can sometimes be noticed within four weeks, the strongest improvements in skin and immune markers tend to emerge after two to four months of consistent use — so patience and consistency are key. Beyond skin, this strain has shown early potential in supporting respiratory health by modulating airway inflammation, and preliminary laboratory research has flagged its ability to reduce oxidative stress in immune cells, an area that scientists are watching closely for future applications.
Common Questions
Frequently Asked Questions
Sources
Scientific References
Curated By

Clara Hayes
Lead Research Editor
Clara leads the curation and verification of microbiome research for our platform. With extensive experience in translating complex scientific literature into accessible insights, she ensures every strain profile is grounded in peer-reviewed evidence and contextual accuracy.
Medical Disclaimer
The information provided on probioticstrains.com is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Strain profiles and clinical summaries are compiled from published peer-reviewed literature. While we may evaluate or highlight specific commercial formulations, our insights are always grounded in available scientific evidence. Always consult a qualified healthcare provider before starting, changing, or stopping any supplement or health regimen.